Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Could this work to prevent blindness and eventually turn back the clock in other organs too?

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

Aging—the progressive decline in our physiological function as we get older—is something many of us hope to slow, stop, or even reverse. Of course, this process is inevitable and something we cannot ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver.